COMMUNIQUÉS West-GlobeNewswire

Takeda announces its intention to acquire TiGenix
05/01/2018
PRESS RELEASE REGULATED INFORMATION Inside Information Communication in accordance with section 8, §1 of the Belgian Royal Decree of 27 April 2007 on public takeover bids Takeda announces its intention to acquire [...]
Takeda annonce son intention d'acquérir TiGenix
05/01/2018
COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉE INFORMATION PRIVILEGIEE Communication conformément à l'article 8, §1 de l'Arrêté Royal belge du 27 avril 2007 relatif aux offres publiques d'acquisition Takeda annonce son [...]
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
05/01/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
Micron Products, Inc. Announces New $9,500,000 Credit Facility
04/01/2018
FITCHBURG, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc. (“Micron”), a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), (“Micron Solutions”, collectively the “Company”) entered [...]
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04/01/2018
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current [...]
Obalon Schedules Fourth Quarter and Full Year 2017 Preliminary, Unaudited Revenue and Business Update Conference Call for January 5, 2018 at 8:30 a.m. Eastern Time
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
MacroGenics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
ROCKVILLE, MD, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
K2M Group Holdings, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
LEESBURG, Va., Jan. 04, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook
04/01/2018
Unaudited Full-Year 2017 Net Product Revenue Estimated Between $177 and $180 Million, Exceeding Upper End of Previously Provided Guidance, with Fourth Quarter Estimate Between $51 and $54 Million Anticipate 2018 Net [...]
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
04/01/2018
BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, [...]
Atara Biotherapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
The Cooper Companies Declares Cash Dividend
04/01/2018
PLEASANTON, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company [...]
MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement
04/01/2018
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) would like comment on the memo issued today from the office of Jeffrey Sessions, Attorney General [...]
Ablexis Announces Licensing of the AlivaMab Mouse to NGM Biopharmaceuticals
04/01/2018
BURLINGAME, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agreement with [...]
Novan Announces Proposed Public Offering of Common Stock and Warrants
04/01/2018
MORRISVILLE, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common [...]
Adventist Health and Cerner Expand Strategic Partnership to Revolutionize Care for Patients, Communities
04/01/2018
ROSEVILLE, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adventist Health announced today an expansion of its partnership with Cerner, a global leader in health care technology. Adventist Health and Cerner have a [...]
T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel
04/01/2018
FDA Clearance of T2Bacteria® Panel remains on track for first quarter 2018 Total revenue expected to exceed the high end of guidance LEXINGTON, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO [...]
REGENXBIO Provides Year-End 2017 Corporate Update
04/01/2018
- Initiated third cohort dosing of RGX-314 Phase I clinical trial for wet AMD - - Initiated second cohort dosing of RGX-501 Phase I/II clinical trial for HoFH - - Anticipate completing dosing and presenting topline [...]
OncoMed Provides 2018 Outlook and 2017 Year-End Cash Balance and Announces an Update on the Rosmantuzumab Program
04/01/2018
Year-end 2017 Cash Balance of $103.1 Million Presentation of Clinical Data on Phase 1 programs expected in 2018 REDWOOD CITY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a [...]

Pages